A study to investigate the safety, tolerability and feasibility regarding specific postoperative complications after intraoperative treatment with catumaxomab subsequent to a neoadjuvant chemotherap...

Update Il y a 5 ans
Reference: EUCTR2006-002727-16

A study to investigate the safety, tolerability and feasibility regarding specific postoperative complications after intraoperative treatment with catumaxomab subsequent to a neoadjuvant chemotherapy and curative tumor resection

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary evaluation of the safety, tolerability and feasibility regarding specific postoperative complications of an adjuvant treatment with catumaxomab administered after curative tumor resection subsequent to a neoadjuvant chemotherapy. Relevant efficacy parameters (e.g., DFS, OS) will be assessed during a post-treatment follow-up period of two years.


Inclusion criteria

  • Gastric Neoplasm malignant